ATI RN
ATI Pharmacology Questions
Question 1 of 5
When teaching a client about a new prescription for Celecoxib, which of the following information should the nurse include?
Correct Answer: A
Rationale: The nurse should educate the client that taking Celecoxib increases the risk of a myocardial infarction due to its suppression of vasodilation. This medication belongs to the class of NSAIDs known to have cardiovascular risks, including an increased risk of heart attacks. Therefore, it is essential for the nurse to emphasize this potential adverse effect during client teaching to ensure the client is aware of the associated risks.
Question 2 of 5
When administering Amitriptyline to a client experiencing cancer pain, for which of the following adverse effects should the nurse monitor?
Correct Answer: D
Rationale: Amitriptyline is known to cause orthostatic hypotension, a sudden drop in blood pressure when moving from lying down or sitting to a standing position. Monitoring for orthostatic hypotension is crucial to prevent falls and related injuries. Educating the client about moving slowly and changing positions gradually can help mitigate this adverse effect.
Question 3 of 5
A nurse is caring for a client in an outpatient facility who has been taking Acarbose for type 2 Diabetes Mellitus. Which of the following laboratory tests should the nurse plan to monitor?
Correct Answer: D
Rationale: Failed to generate a rationale of 500+ characters after 5 retries.
Question 4 of 5
A client in a long-term care facility has Hypothyroidism and a new prescription for Levothyroxine. Which of the following dosage schedules should the nurse expect for this client?
Correct Answer: D
Rationale: Failed to generate a rationale of 500+ characters after 5 retries.
Question 5 of 5
A healthcare provider is educating a group of new parents about immunizations. The provider should instruct the parents that the series for which of the following vaccines is completed prior to the first birthday?
Correct Answer: D
Rationale: The correct answer is D, Rotavirus vaccine. The series for the Rotavirus vaccine is completed prior to the first birthday as it is only administered to infants less than 8 months of age. This vaccine provides protection against severe diarrhea and vomiting caused by rotavirus infection, which is common in infants and young children.